Biting back: BiTE antibodies as a promising therapy for acute myeloid leukemia.
about
Novel immunotherapies for hematologic malignanciesTrial Watch-Immunostimulation with cytokines in cancer therapyThe Broad Anti-AML Activity of the CD33/CD3 BiTE Antibody Construct, AMG 330, Is Impacted by Disease Stage and RiskAntibody Therapies in Cancer.Classification of current anticancer immunotherapiesSpontaneous remission of acute myeloid leukemia.Emerging therapeutic targets for the treatment of human acute myeloid leukemia (part 1) - gene transcription, cell cycle regulation, metabolism and intercellular communication.Emerging therapeutic targets in human acute myeloid leukemia (part 2) - bromodomain inhibition should be considered as a possible strategy for various patient subsets.Paradigm shift in bacteriophage-mediated delivery of anticancer drugs: from targeted 'magic bullets' to self-navigated 'magic missiles'.Acute myeloid leukemia targets for bispecific antibodies.Trial watch: Tumor-targeting monoclonal antibodies for oncological indications.
P2860
Q27004436-5C1A4D5F-94EC-4225-B3C4-0B804AA8D5BEQ28078725-2A2B78B7-2BD5-462F-9191-CC568FB8D166Q28547458-535A6DCB-677B-43A8-B4EB-7BEAB5E84771Q31104000-F01E04B0-9D3D-4BDE-9AB2-67D318B8E498Q35149637-8FD0D878-C071-43F0-B460-328788821905Q38256921-178D3945-49E0-4F2E-886C-F89AFA9813BAQ38401664-A7442A89-4A6E-4F83-BDC2-6A1B389AA372Q38435352-B2A2F73F-9270-4F6B-A7DE-223E642EB540Q38910806-1C496534-CCFF-49BC-9696-D3695A1D7C7FQ39117761-F692D727-9CFB-49E7-86D6-FA23A158EF63Q42558833-81C7DD87-400B-4402-BC13-CA12101DA8F8
P2860
Biting back: BiTE antibodies as a promising therapy for acute myeloid leukemia.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Biting back: BiTE antibodies as a promising therapy for acute myeloid leukemia.
@en
Biting back: BiTE antibodies as a promising therapy for acute myeloid leukemia.
@nl
type
label
Biting back: BiTE antibodies as a promising therapy for acute myeloid leukemia.
@en
Biting back: BiTE antibodies as a promising therapy for acute myeloid leukemia.
@nl
prefLabel
Biting back: BiTE antibodies as a promising therapy for acute myeloid leukemia.
@en
Biting back: BiTE antibodies as a promising therapy for acute myeloid leukemia.
@nl
P2860
P1476
Biting back: BiTE antibodies as a promising therapy for acute myeloid leukemia.
@en
P2860
P304
P356
10.1586/17474086.2014.896190
P577
2014-03-11T00:00:00Z